Oct 2026
Structure-based drug repurposing for CDK6: Molecular docking and molecular dynamics characterization of FDA-approved non-oncological compounds.
Structural, conformational, energetic, and pharmacokinetic characterization of dutasteride, danazol, and azelastine as candidate CDK6-binding scaffolds are provided.
Syarifuddin Husain, Ruzianisra Mohamed, Khairul Bariyyah Abd. Halim et al.
· Journal of Molecular Graphic... · 0 citations